Loading...
Back to narrative

Update shared on18 Sep 2025

Fair value Decreased 1.34%
AnalystConsensusTarget's Fair Value
US$36.83
30.7% undervalued intrinsic discount
18 Sep
US$25.51
Loading
1Y
-31.4%
7D
-3.7%

The modest reduction in Keurig Dr Pepper's analyst price target to $36.83 reflects increased concerns over execution risks and margin dilution related to the JDE Peet’s acquisition and planned spin-off, partly offset by some optimism regarding long-term growth prospects and current valuation.


Analyst Commentary


  • Mixed market reaction and price target adjustments largely reflect concerns over the complexity and high risk of the JDE Peet's acquisition and planned spin-off, including the company’s increased debt load and deal-related margin dilution.
  • Bullish analysts see strategic value in a globally diversified beverage operation and anticipate potential for higher trading multiples if a standalone cold beverage business emerges.
  • Bearish analysts highlight investor preference for a clearer business structure, specifically separating the coffee segment from soft drinks, rather than a complex merger and spin-off process.
  • Several analysts maintain Buy/Overweight ratings, citing visible long-term organic sales growth outperformance, resilient U.S. Refreshment and International segments, and attractive current valuation relative to peers.
  • Ongoing analyst caution centers on the market’s initial negative reaction to the deal, questions over Keurig Dr Pepper's ability to de-lever, and uncertainties about future debt allocation between the business units.

What's in the News


  • Keurig Dr Pepper is close to acquiring JDE Peets for approximately $18 billion; the combined entity plans to separate its beverage and coffee businesses (Wall Street Journal).
  • The company announced an expansive advertising partnership with Disney Advertising, focusing on delivering personalized consumer experiences, data-driven marketing, and innovative mixed-reality activations for Dr Pepper integrated into college football broadcasts (Key Developments).
  • A new documentary-style social series will highlight the 17-year history of the Dr Pepper Tuition Giveaway and its impact on past winners as part of the Disney partnership (Key Developments).
  • Keurig Dr Pepper reaffirmed its fiscal 2025 financial guidance, expecting mid-single-digit constant currency net sales growth for the year (Key Developments).
  • The company reported no additional share repurchases in Q2 2025, completing its previously announced $2.19 billion buyback program, and separately launched a limited-edition collaboration with Chillhouse to promote barista-style iced coffee and branded press-on nails (Key Developments).

Valuation Changes


Summary of Valuation Changes for Keurig Dr Pepper

  • The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from $37.33 to $36.83.
  • The Future P/E for Keurig Dr Pepper remained effectively unchanged, moving only marginally from 17.40x to 17.17x.
  • The Net Profit Margin for Keurig Dr Pepper remained effectively unchanged, at 14.79%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.